HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tan Lixin Selected Research

Antirheumatic Agents (DMARD)

9/2010Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tan Lixin Research Topics

Disease

1Experimental Arthritis
09/2010
1Rheumatoid Arthritis
09/2010

Drug/Important Bio-Agent (IBA)

1Folic Acid (Vitamin M)FDA LinkGeneric
09/2010
1Methotrexate (Mexate)FDA LinkGeneric
09/2010
1Proteins (Proteins, Gene)FDA Link
09/2010
1CytokinesIBA
09/2010
1Antirheumatic Agents (DMARD)IBA
09/2010
1Collagen Type II (Type II Collagen)IBA
09/2010

Therapy/Procedure

1Therapeutics
09/2010